Graduated blood-alcohol limits to protect 21–24 year-old drivers
Modeling a national Graduated-BAC per se policy for 21-24 y/o drivers to reduce alcohol impaired driving injury and fatal crashes
This project models whether lowering legal blood-alcohol limits for 21–24-year-old drivers could prevent alcohol-related crashes, injuries, and deaths.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-11184512 on NIH RePORTER |
What this research studies
As a 21–24-year-old driver, you are in a group with higher risk of serious crashes after drinking. The team will use national crash, hospital, and alcohol-use data to build computer simulations that compare the current .08 BAC limit to graduated, lower BAC limits for 21–24-year-olds. They will estimate expected changes in injuries, deaths, and the societal costs under several policy scenarios. Results are intended to inform lawmakers about how changing legal BAC thresholds might improve safety for young adults.
Who could benefit from this research
Good fit: The primary population of interest is drivers aged 21–24, especially those who consume alcohol or are at risk of driving after drinking.
Not a fit: People older than 24, non-drivers, or individuals who do not drink alcohol would not directly benefit from this specific policy change.
Why it matters
Potential benefit: If successful, the work could support laws that reduce alcohol-related injuries and fatalities among 21–24-year-old drivers.
How similar studies have performed: Lower BAC limits and zero-tolerance rules for under-21 drivers have been linked to fewer crashes, but applying a graduated BAC policy for 21–24-year-olds is less commonly tested and mostly explored through modeling.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Vaca, Federico E — University of California-Irvine
- Study coordinator: Vaca, Federico E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.